Home > Products > Novel inhibitors

Ozogamicin

  Cat. No.:  DC46088  
Chemical Structure
400046-53-9
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Ozogamicin is a drug-linker conjugates for ADC. Ozogamicin can used in the synthesis of gemtuzumab ozogamicin and inotuzumab ozogamicin.
Chemicals PropertiesBiological activity COA & MSDSRelated productsDatasheet
Cas No.: 400046-53-9
Chemical Name: Ozogamicin
SMILES: C/C(C1=CC=C(C=C1)OCCCC(N)=O)=N\NC(CC(C)(C)SSC/C=C2C([C@H](C#C/C=C\C#C[C@@]\2(C3)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C)NO[C@H]5C[C@@H]([C@@H]([C@H](O5)C)SC(C6=C(C(OC)=C(C(I)=C6C)O[C@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)C)O)OC)O)OC)=O)O)O)O[C@H]8C[C@@H]([C@H]
Formula: C73H97In6O25S3
M.Wt: 1681.68
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC47681 PNU-EDA-Gly5 PNU-EDA-Gly5 is an oligo-glycine linker-payload for ADC synthesis, composed of a DNA topoisomerase I inhibitor PNU-159682 and a linker EDA-Gly5.
DC47680 PSMA-Val-Cit-PAB-MMAE PSMA-Val-Cit-PAB-MMAE is a novel small-molecule PSMA-targeted conjugate based on the monomethyl auristatin E for the chemotherapy of prostate cancer.
DC47148 Mal-(CH2)5-Val-Cit-PAB-Eribulin Mal-(CH2)5-Val-Cit-PAB-Eribulin is a drug-linker conjugate for ADC with potent antitumor activity by using the anti-microtubule agent, Eribulin, linked via linker Mal-(CH2)5-Val-Cit-PAB.
DC46407 Desmethyl Vc-seco-DUBA Desmethyl Vc-seco-DUBA consists a cleavable ADC linker (Desmethyl Vc-seco) and a DNA alkylating agent (DUBA). Desmethyl Vc-seco-DUBA can be used in the synthesis of antibody-drug conjugates (ADCs).
DC46251 Azide-PEG4-VC-PAB-Doxorubicin Azide-PEG4-VC-PAB-Doxorubicin is a drug-linker conjugate composed of a cytotoxic anthracycline antibiotic Doxorubicin and a linker Azide-PEG4-VC-PAB to make antibody drug conjugate (ADC).
DC46238 MC-Val-Cit-PAB-dimethylDNA31 MC-Val-Cit-PAB-dimethylDNA31 is a drug-linker conjugate for ADC with potent antitumor activity by using dimethylDNA31, linked via the ADC linker MC-Val-Cit-PAB. DimethylDNA31 has effective bactericidal activity against persisters and stationary-phase S. aureus.
DC46213 OSu-PEG4-VC-PAB-Duocarmycin SA SA is a drug-linker conjugate for ADC with potent antitumor activity by using Duocarmycin SA (a potent DNA alkylation activator), linked via the cleavable ADC linker OSu-PEG4-VC-PAB.
DC46212 MAC-VC-PABC-ST7612AA1 MAC-VC-PABC-ST7612AA1 is a part of antibody drug conjugates (ADCs) charged with HDAC inhibitor by a linker, shows antitumor activity.
DC46211 FCHFHS-ST7612AA1 FCHFHS-ST7612AA1 is a part of antibody drug conjugates (ADCs) charged with HDAC inhibitor by a linker, shows antitumor activity.
DC46204 N3-PEG8-Phe-Lys-PABC-Gefitinib N3-PEG8-Phe-Lys-PABC-Gefitinib is a drug-linker conjugate for ADC with potent antitumor activity by using the anti-tumor agent, Gefitinib (orally active EGFR tyrosine kinase inhibitor), linked via the cleavable linker N3-PEG8-Phe-Lys-PABC.
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia